ISSN 1004-4140
CN 11-3017/P
DAI M L, DONG J Y, PAN Y L, et al. Application of CT in the prognostic analysis of ureteral carcinoma[J]. CT Theory and Applications, 2022, 31(5): 679-685. DOI: 10.15953/j.ctta.2021.010. (in Chinese).
Citation: DAI M L, DONG J Y, PAN Y L, et al. Application of CT in the prognostic analysis of ureteral carcinoma[J]. CT Theory and Applications, 2022, 31(5): 679-685. DOI: 10.15953/j.ctta.2021.010. (in Chinese).

Application of CT in the Prognostic Analysis of Ureteral Carcinoma

More Information
  • Received Date: October 04, 2021
  • Accepted Date: December 01, 2021
  • Available Online: December 05, 2021
  • Published Date: September 30, 2022
  • Objective: To discuss the application value of CT in the prognostic analysis of ureteral carcinoma. Methods: The CT and medical records of 101 patients with ureteral carcinoma who underwent radical nephroureterectomy from January 2014 to December 2016 were collected and analyzed, and then the Cox regression method was performed. Results: Cox uni-variate analysis revealled that the single risk factors affecting the survival rate of patients with ureteral cancer in CT signs included multiple lesions, necrotic cystic change, maximum diameter ≥3 cm, peritumoral fat infiltration and depth of infiltration, invasion of adjacent organs and tissues, and lymph node metastasis. Cox multi-variate analysis,revealled that the multiple risk factors affecting the long-term survival rate of patients with ureteral cancer in CT signs included peritumoral fat infiltration and depth of infiltration, invasion of adjacent organs and tissues, lymph node metastasis, tumor necrosis and cyst, and multiple lesions. Conclusion: In CT signs, peritumoral fat infiltration and depth of infiltration, invasion of adjacent organs and tissues, lymph node metastasis, tumor necrosis and cystic degeneration and multiple lesions are the main risk factors affecting the survival of patients with ureteral cancer. CT holds great application value in the prognostic analysis of primary ureteral cancer.
  • [1]
    ROUPRET M, ZIGEUNERI R, PALOU J, et al. European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update[J]. European Urology, 2011, 59(4): 584−594. doi: 10.1016/j.eururo.2010.12.042
    [2]
    MARGULIS V, SHARIAT S F, MATIN S F, et al. Outcomes of radical nephroureterectomy: A series from the upper tract urothelial carcinoma collaboration[J]. Cancer, 2009, 115(6): 1224−1233. doi: 10.1002/cncr.24135
    [3]
    ROUPRET M, BABJUK M, COMPERAT E, et al. European association of urology guidelines on upper urinary tract urothelial carcinoma: 2017 update[J]. European Urology, 2018, 73(1): 111−122. doi: 10.1016/j.eururo.2017.07.036
    [4]
    LEHMANN J, SUTTMANN H, KOVAC I, et al. Transitional cell carcinoma of the ureter: Prognostic factors influencing progression and survival[J]. European Urology, 2007, 51(5): 1281−1288. doi: 10.1016/j.eururo.2006.11.021
    [5]
    PARIZI M K, GLYBOCHKO P V, ENIKEEV D, et al. Risk stratification of upper tract urothelial carcinoma: A review of the current literature[J]. Expert Review of Anticancer Therapy, 2019, 19(6): 503−513. doi: 10.1080/14737140.2019.1621753
    [6]
    ABOUASSALY R, ALIBHAI S M H, SHAH N, et al. Troubling outcomes from population-level analysis of surgery for upper tract urothelial carcinoma[J]. Urology, 2010, 76(4): 895−901. doi: 10.1016/j.urology.2010.04.020
    [7]
    GAKIS G, WITJES J A, COMPERAT E, et al. EAU guidelines on primary urethral carcinoma[J]. European Urology, 2013, 64(5): 823−830. doi: 10.1016/j.eururo.2013.03.044
    [8]
    安宁豫, 江波, 蔡幼铨, 等. 原发输尿管癌的MRI诊断并与其他影像诊断方法的比较[J]. 中华放射学杂志, 2004,38(8): 811−815. doi: 10.3760/j.issn:1005-1201.2004.08.006

    AN N Y, JIANG B, CAI Y Q, et al. Primary ureteral carcinoma: MRI diagnosis and comparison with other diagnostic imaging facilities[J]. Chinese Journal of Radiology, 2004, 38(8): 811−815. (in Chinese). doi: 10.3760/j.issn:1005-1201.2004.08.006
    [9]
    ROUPRET M, BABJUK M, COMPERAT E, et al. European guidelines on upper tract urothelial carcinomas: 2013 update[J]. European Urology, 2013, 63(6): 1059−1071. doi: 10.1016/j.eururo.2013.03.032
    [10]
    LI C C, CHANG T H, WU W J, et al. Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients[J]. European Urology, 2008, 54(5): 1127−1135. doi: 10.1016/j.eururo.2008.01.054
    [11]
    万绪明, 侯艳玲, 于忠海. 原发性输尿管癌与输尿管转移癌的螺旋 CT 诊断[J]. 临床放射学杂志, 2010,29(7): 985−987.

    WAN X M, HOU Y L, YU Z H. Helical CT diagnosis of the primary ureteral carcinoma and ureteral metastatic carcinoma[J]. Journal of Clinical Radiology, 2010, 29(7): 985−987. (in Chinese).
    [12]
    张秀丽, 吕申, 王朝晖, 等. 输尿管癌“环/线”状CT强化征及其临床意义[J]. 中国医学影像技术, 2013,29(7): 1155−1159.

    ZHANG X L, LV S, WANG C H, et al. CT imaging of ureteral carcinoma: A "ring/line" enhancement sign and its clinical significance[J]. Chinese Journal of Medical Imaging Technology, 2013, 29(7): 1155−1159. (in Chinese).
    [13]
    FAVARETTO R L, SHARIAT S F, SAVAGE C, et al. Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle-invasive and non-organ confined disease in patients with upper tract urothelial carcinoma[J]. BJU International, 2012, 109(1): 77−82. doi: 10.1111/j.1464-410X.2011.10288.x
    [14]
    COWAN N C, TURNEY B W, TAYLOR N J, et a1. Multidetector computed tomography urography for diagnosing upper urinary tract urothelial tumour[J]. BJU International, 2007, 99(6): 1363−1370. doi: 10.1111/j.1464-410X.2007.06766.x
    [15]
    ZEIKUS E, SURA G, HINDMAN N, et a1. Tumors of renal collecting systems, renal pelvis, and ureters: Role of MR imaging and MR urography versus computed tomography urography[J]. Magnetic Resonance Imaging Clinics of North America, 2019, 27(1): 15−32. doi: 10.1016/j.mric.2018.09.002
    [16]
    YAN S B, LIU L R, WEI Q, et al. Impact of tumour size on prognosis of upper urinary tract urothelial carcinoma after radical nephroureterectomy: A multi institutional analysis of 795 cases[J]. BJU International, 2016, 118(6): 902−910. doi: 10.1111/bju.13463
    [17]
    MILOJEVIC B, DJOKIC M, MILENKOVIC D, et al. The impact of tumor size on outcomes in patients with upper urinary tract urothelial carcinoma[J]. European Urology Supplements, 2013, 12(4): e1219−S111.
    [18]
    ZHANG X K, ZHANG Z L, YANG P, et al. Tumor necrosis predicts poor clinical outcomes in patients with node-negative upper urinary tract urothelial carcinoma[J]. Japanese Journal of Clinical Oncology, 2015, 45(11): 1069−1075. doi: 10.1093/jjco/hyv127
    [19]
    LEE S E, HONG S K, HAN B K, et a1. Prognostic significance of tumor necrosis in primary transitional cell carcinoma of upper urinary tract[J]. Japanese Journal of Clinical Oncology, 2007, 37(1): 49−55. doi: 10.1093/jjco/hyl123
    [20]
    ZIGEUNER R, SHARIAT S F, MARGULIS V, et al. Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract[J]. European Urology, 2010, 57(4): 575−581. doi: 10.1016/j.eururo.2009.11.035
    [21]
    CHROMECKI T F, CHA E K, FAJKOVIC H, e al. The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy[J]. European Urology, 2012, 61(4): e75−e76.
  • Cited by

    Periodical cited type(3)

    1. 贡勉,齐良波. 膀胱癌患者癌组织中USP8、USP15、USP18水平与临床病理特征的关系. 检验医学与临床. 2025(05): 683-689 .
    2. 陈阿芬,林玉枝. 医护一体化心理干预对膀胱癌术后造口患者治疗依从性、自我管理效能的影响. 国际护理学杂志. 2025(02): 338-342 .
    3. 徐娜,孟庆涛,罗元满,褚雨露. 基于VI-RADS评分的多参数MRI对膀胱癌术前T分期诊断的临床价值. 中国CT和MRI杂志. 2025(04): 143-146 .

    Other cited types(0)

Catalog

    Article views (250) PDF downloads (42) Cited by(3)
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return